Will RBI penalize individuals for holding multiple bank accounts? Here’s what Govt says!

Is it illegal to have multiple bank accounts in India? Or, you can’t have more than one bank account henceforth? If some recent news reports are to be believed, as per the new guidelines by the Reserve Bank of India, a penalty will now be imposed on people with multiple bank accounts or bank accounts in more than one bank.

However, you need not panic as these news reports are fake, and the RBI is not going to impose any penalty on people for having multiple bank accounts or bank accounts in more than one bank.

After checking the facts, the Press Information Bureau (PIB) has recently released its Fake News Alert, sharing a post on its official X handle, that this news is fake and the RBI hasn’t issued any guideline for imposing a penalty on people for having bank accounts in more than one bank. So, “you need to be alert to such fake news!”

It is clear, thus, that the recent viral news about the RBI planning to penalize individuals for holding multiple bank accounts is fake. So, there is no need to panic or rush to close your accounts.

Also Read: SIP Investment: 5 common mistakes to avoid to make the most of SIPs

Otherwise also, there is no restriction on the number of bank accounts that a person or his family can keep in India, and people are legally allowed to have as many bank accounts as possiple. Numerous persons also like to keep multiple bank accounts for multiple needs.

Financial experts, however, advise people to restrict the number of their bank accounts to a maximum of 2 or 3 as having too many bank accounts without any purpose may be difficult to manage and you will also be required to keep a minimum bank balance in all the accounts, failing which banks may levy non-maintenance charges.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations